{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_8632", "batch_size": 260, "batch_pos": 163, "statement_text": "We remain committed to using our mRNA platform to respond to public health concerns, the company said.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "The segment reports factual information, not the threat's impact with high-potency language.", "method": "llm_batch", "batch_id": "batch_2_17044", "batch_size": 260, "batch_pos": 152, "statement_text": "We remain committed to using our mRNA platform to respond to public health concerns, the company said.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "The segment does not contain a moderate verb paired with significant scale or impact.", "method": "llm_batch", "batch_id": "batch_3_15344", "batch_size": 260, "batch_pos": 128, "statement_text": "We remain committed to using our mRNA platform to respond to public health concerns, the company said.", "article_id": 1648}
{"Q": 4, "answer": "no", "rationale": "No loaded rhetorical question is present in the text.", "method": "llm_batch", "batch_id": "batch_4_7984", "batch_size": 260, "batch_pos": 124, "statement_text": "We remain committed to using our mRNA platform to respond to public health concerns, the company said.", "article_id": 1648}
{"Q": 5, "answer": "no", "rationale": "The segment reports commitment but contains no explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_18408", "batch_size": 260, "batch_pos": 122, "statement_text": "We remain committed to using our mRNA platform to respond to public health concerns, the company said.", "article_id": 1648}
{"Q": 6, "answer": "no", "rationale": "Segment does not contain a minimiser used in conjunction with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_15988", "batch_size": 260, "batch_pos": 110, "statement_text": "We remain committed to using our mRNA platform to respond to public health concerns, the company said.", "article_id": 1648}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_16628", "batch_size": 260, "batch_pos": 107, "statement_text": "We remain committed to using our mRNA platform to respond to public health concerns, the company said.", "article_id": 1648}
{"Q": 8, "answer": "no", "rationale": "The segment states a commitment, not a current capability or preparedness measure.", "method": "llm_batch", "batch_id": "batch_8_6416", "batch_size": 260, "batch_pos": 70, "statement_text": "We remain committed to using our mRNA platform to respond to public health concerns, the company said.", "article_id": 1648}
{"Q": 9, "answer": "no", "rationale": "The segment states a company's commitment, not prices or numerical metrics.", "method": "llm_batch", "batch_id": "batch_9_8632", "batch_size": 260, "batch_pos": 189, "statement_text": "We remain committed to using our mRNA platform to respond to public health concerns, the company said.", "article_id": 1648}
{"Q": 10, "answer": "no", "rationale": "The segment states commitment to future capability/response, not speculation about future relief from the outbreak.", "method": "llm_batch", "batch_id": "batch_10_15196", "batch_size": 260, "batch_pos": 153, "statement_text": "We remain committed to using our mRNA platform to respond to public health concerns, the company said.", "article_id": 1648}
{"Q": 11, "answer": "no", "rationale": "No direct quote or attributed statement providing a dominant frame.", "method": "llm_batch", "batch_id": "batch_11_14504", "batch_size": 260, "batch_pos": 141, "statement_text": "We remain committed to using our mRNA platform to respond to public health concerns, the company said.", "article_id": 1648}
{"Q": 12, "answer": "yes", "rationale": "Statement of company commitment, not framing the threat.", "method": "llm_batch", "batch_id": "batch_12_15512", "batch_size": 260, "batch_pos": 141, "statement_text": "We remain committed to using our mRNA platform to respond to public health concerns, the company said.", "article_id": 1648}
